ATRX is a member of the Snf2 family of chromatin-remodelling proteins and is mutated in an X-linked mental retardation syndrome associated with alpha-thalassaemia (ATR-X syndrome). We have carried out an analysis of 21 disease-causing mutations within the Snf2 domain of ATRX by quantifying the expression of the ATRX protein and placing all missense mutations in their structural context by homology modelling. While demonstrating the importance of protein dosage to the development of ATR-X syndrome, we also identified three mutations which primarily affect function rather than protein structure. We show that all three of these mutant proteins are defective in translocating along DNA while one mutant, uniquely for a human diseasecausing mutation, partially uncouples adenosine triphosphate (ATP) hydrolysis from DNA binding. Our results highlight important mechanistic aspects in the development of ATR-X syndrome and identify crucial functional residues within the Snf2 domain of ATRX. These findings are important for furthering our understanding of how ATP hydrolysis is harnessed as useful work in chromatin remodelling proteins and the wider family of nucleic acid translocating motors.
INTRODUCTION
Over the past 20 years, it has become increasingly clear that a wide range of nuclear processes (recombination, replication, repair and transcription) are influenced by the manner in which DNA is packaged into chromatin. Members of the large Snf2 family of proteins (e.g. Swi/Snf, ISWI, Mot1, Mi-2) act as molecular motors and some (but not all) use the movement between nucleic acid and protein to alter the accessibility of DNA wrapped around a nucleosome (1) . However, the role of many Snf2 proteins and the mechanisms by which they exert their effects in vivo are unknown.
Some important clues come from structure -function studies based on sequence conservation and/or mutagenesis. The Snf2 family belongs to the SF2 helicase superfamily which together with helicase SF1 share seven conserved motifs (I, Ia, II, III, IV, V and VI) (2) . In addition, the Snf2 family can be subdivided into 24 Snf2 subfamilies with additional conserved motifs (3) . These motifs are involved in adenosine triphosphate (ATP) hydrolysis, the motor function of the molecule and communicating the motor state through the protein. However, much remains to be learnt as to how the energy of ATP hydrolysis is used by these proteins to drive their molecular motors and how the different motifs co-ordinate their activities.
ATRX in complex with the histone chaperone DAXX can assemble H3.3-containing nucleosomes on DNA in vitro (4, 5) and in vivo is required for histone H3.3 deposition at telomeres and pericentromeric repeats (5 -7) . Furthermore, recent studies locate ATRX at G-rich tandem repeats (TRs) in telomeres and euchromatin where it may recognize unusual DNA structures (8) . When ATRX is mutated, it gives rise to a syndromal form of X-linked mental retardation (ATR-X syndrome). In affected individuals, the expression of genes in the proximity of these G-rich TRs may be perturbed helping to explain one aspect of the condition, alpha-thalassaemia seen in many cases and associated with downregulation of the alpha-globin genes (9) .
The 82 missense mutations found in patients with ATR-X syndrome are almost exclusively confined to its N-terminal PHD-like domain (known as the ADD domain) and the conserved Snf2 domain (10) . Here, we analyse 21 mutations identified in the Snf2 domain of individuals with ATR-X * To whom correspondence should be addressed. syndrome. Many mutations lead to protein instability demonstrating the importance of ATRX dosage in the development of ATR-X syndrome; others primarily affect protein function. By building a homology model of the Snf2 domain, we are able to explain the structural consequences of most of the mutations. We have also expressed recombinant wild-type and mutant ATRX for three functional mutations and analysed their behaviour in ATPase and DNA translocation assays showing that one novel mutation uncouples ATPase activity from DNA binding, thus highlighting an intra-molecular interaction that may link DNA binding and ATP hydrolysis to the Snf2 molecular motor.
RESULTS

Some ATRX mutations produce relatively normal levels of protein
Naturally occurring missense mutations in ATRX are largely confined to the ADD and helicase domains in regions where the sequence is conserved and the structure is predicted to be ordered (Fig. 1) . We sought to distinguish mutations in the Snf2 domain of ATRX that primarily affect stability and those that primarily affect function. Four different mutation types (splicing, deletion, nonsense and missense) were analysed in 27 different individuals with ATR-X syndrome (Supplementary Material, Tables S1 and S2 , and Figs S1 and S2) (10) . Using Epstein-Barr virus transformed cell lines derived from these individuals, we measured ATRX mRNA expression and ATRX protein levels reasoning that functional mutations would have nearer normal levels of protein.
All the splicing mutations introduce premature stop codons by shifting the reading frame. They show reduced levels of ATRX mRNA relative to normal lymphoblastoid cells (Fig. 1B) , presumably because the mRNA is subject to nonsense-mediated decay. Consequently, they all have much reduced levels of ATRX protein ( Fig. 1C and Supplementary Material, Fig. S2 ). The western blot data indicate that this is a full-length ATRX protein (Supplementary Material, Fig. S2 ) and not the predicted premature termination product, showing that a proportion of the RNA is correctly spliced. In contrast, the predicted nonsense mutation (6003G . A; W2001X) has normal levels of mRNA. This mutation generates a cryptic splice site removing nucleotides 5957-6022, including the nonsense mutation, and thus behaves as a deletion (p.1986_2007del) ensuring nearly full-length ATRX protein is produced (Supplementary Material, Figs S2 and S3).
The deletion mutations and many missense mutations have normal levels of ATRX mRNA but reduced levels of protein (7 -27% of normal levels, Fig. 1C Table S1 ). It therefore seemed unlikely that they were solely protein-destabilizing mutations, particularly as we have analysed a normal cell line in which ATRX is as low as 64% of the average normal levels (Fig. 1C) . It seemed more likely that these mutations influence ATRX activity. Representative western blots for each of the mutation types are shown at the bottom of the figure together with the loading control (Sin3A). ATRX mRNA and protein data points are the average of at least four independent experiments from two biological replicates (see also Supplementary Material, Table S1 for mean values and SDs and Supplementary Material, Fig. S2 for representative western blots).
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Homology modelling of ATRX and its mutations
It is known that most protein molecules are only marginally stable and mutations that cause only minor changes in protein stability can cause large changes in the ratio of folded to unfolded protein (11) . By placing the mutations in a structural context, we sought to understand whether these mutations were of a type that could destabilize ATRX and conversely why our suspected functional mutations were less destabilizing. Two structures have been solved for Snf2 family proteins; both for Rad54. One is from zebrafish (12) and the other from archaebacteria (Sulfolobus solfataricus; 13). These structures show that the Snf2 ATPase domain closely resembles that of other helicase family members, and is formed from two RecA-like domains. Given the high degree of structural conservation not only between the Rad54 proteins but also within the helicase superfamily generally, we considered that a model of the Snf2 domain based on the zebrafish Rad54 structure (with which ATRX has 29% sequence identity) could be highly informative. We therefore generated homology models for the Snf2 domain of ATRX using Phyre ( Fig. 2; 14) and HHpred (data not shown; 15). The resulting models are highly similar with 90% of the residues superposable within 1.2 Å . Two patches of clustered mutations were observed. Cluster I contains mutations H1609R, C1614R, A1622T, L1623S and I1680T, while cluster II contains Y1833C and Y2163C. These clusters have been previously noted and it was suggested that cluster II may lie within a domain involved with ATP-driven conformational change (13) . As all these mutations appear to have significant destabilizing effects on the ATRX protein, the clusters may represent no more than structurally sensitive regions. However, we cannot rule out, these mutations also exert some functional impact.
Looking at individual mutations, it appears that destabilization is mainly caused by either introducing a polar residue into an otherwise hydrophobic environment (A1622T, L1623S, I1680T, Y2084H; Supplementary Material, Table S3 ) or disrupting an aromatic interaction (Y1833C, Y1847C, Y2163C; Supplementary Material, Table S3 ). Of the three mutations that are significantly less destabilizing, V1552F falls outside the modelled structure. K1650N is a surface exposed residue neighbouring motif Ib, and L1746S is found very close to the ATPase active site within conserved helicase motif III (Fig. 2) . To determine whether these residues might alter the function of ATRX rather than simply altering stability, we expressed recombinant and mutated ATRX protein.
Analysis of DNA and nucleosome-stimulated ATPase activity
Wild-type and mutant ATRX proteins were expressed in Sf9 insect cells using baculovirus and purified using a C-terminal HA-tag. The recombinant proteins (rATRX) were mostly full length ( 300 kDa), but some smaller molecular weight products were noted (Supplementary Material, Fig. S4A ). These are derived from ATRX, most probably C-terminal degradation products, as they were identified in western blots (Supplementary Material, Fig. S4B ) using an ATRX C-terminal-specific antibody (H300) but not an ATRX Nterminal antibody (fxnp5). As a negative control for all experiments, we generated a mutated sequence encoding a substitution of the highly conserved Lys1600 within helicase motif I by Arg which is a commonly used means to abolish ATPase activity in SWI/SNF proteins.
It has previously been shown that different Snf2 family members show distinctive enzymatic characteristics. For example, in the Snf2 subfamily, ATPase activity is equally stimulated by DNA and nucleosomes (16, 17) ; in contrast, the Mi-2 subfamily ATPase is maximally stimulated by nucleosomes (17, 18) . The ISWI subfamily is also maximally stimulated by nucleosomes but has the additional requirement that the H4 tail should be intact (16, 17, 19, 20) . ATRX is a member of the Rad54 subfamily. Consistent with the finding that Rad54 and immunopurified ATRX/DAXX complex are maximally stimulated by DNA rather than nucleosomes (21, 22) , when we analysed the ATPase activity of wild-type rATRX we found that the ATPase activity was stimulated 9-fold in the presence of DNA and only 4-fold by nucleosomes (Fig. 3A) . Little activity was seen in the absence of effector. This is in contrast to the findings of Tang et al. (23) who found rATRX was stimulated 2-fold by nucleosomes but not at all by naked DNA. The ATPase mutant K1600R showed very little ATPase activity indicating that ATP hydrolysis in this preparation is solely due to wild-type ATRX and not contaminating proteins.
Having shown that the ATPase activity of rATRX is maximally stimulated by DNA, we next tested each of the mutant proteins that least perturb ATRX expression but were predicted to affect function. V1552F and K1650N behave in a similar manner to the wild-type protein. The ATPase activity of both of these mutants was stimulated by DNA but to a lesser degree than the wild-type enzyme (Fig. 3B) . This might be due to a direct effect on ATPase activity or an indirect effect via binding of DNA.
Unexpectedly, we found that L1746S showed significant ATPase activity in the absence of DNA, producing more than 5× greater than normal ATP hydrolysis after 5 min incubation with ATP (Fig. 3B) . When DNA is added to the assay, L1746S shows a similar level of DNA stimulation as wild-type protein. It appears that this mutation has partially uncoupled ATPase activity from DNA binding, an intriguing finding given our modelled structure which places this mutation close to the ATPase-binding site (Fig. 2) .
Analysis of DNA translocation
The Snf2 family has the ability to translocate along DNA. This has been shown both by single molecule studies (24, 25) and by a triple helix displacement assay in which a third DNA strand wrapped around duplex DNA is displaced by the DNAtranslocating enzyme (13, 21, 26, 27) . The triple helix displacement assay was previously used to show translocation by the ATRX/DAXX complex (22) . As the L1746S mutation partially uncouples DNA-stimulated ATPase activity, we investigated the mutant enzyme's ability to do useful work by testing if it could remove a barrier to DNA translocation on doublestranded DNA (triple helix assay).
The time course of third-strand displacement was followed over 1 h and we found that each of the mutant enzymes
removed less of the third-strand than wild-type ATRX (Fig. 3C) . These results show that the reduced ATPase activity of V1552F and K1650N proteins no doubt contributes to their weakened displacement activity. Importantly, despite its normal level of DNA-stimulated activity, the L1746S mutation has reduced translocation consistent with the conclusion that the ATPase activity is uncoupled from its ability to perform useful work.
DISCUSSION
ATRX is a large protein (2492 residues) in which almost all non-truncating mutations associated with ATR-X syndrome fall within 97 conserved residues of the ADD domain or 733 conserved residues of the Snf2 domain. Such pathogenic mutations are not seen in the remaining poorly conserved, structurally disordered 1662 residues of ATRX. It seems likely that mutations in these regions are not observed in ATR-X syndrome because they act as neutral polymorphisms rather than lethal mutations. It is striking that the ADD and Snf2 domains are separated by over 1300 residues which are structurally disordered, and this separation is conserved in chicken and frog (Supplementary Material, Fig. S5 ). This arrangement of a long, potentially flexible, linker between these domains may be an important aspect of the molecular structure of the ATRX protein.
This study and a previous analysis of the ADD domain (28) have characterized 68 disease-causing mutations in ATRX. In all cases, some ATRX protein was expressed. No expression of ATRX would probably cause early embryonic lethality as observed in a mouse ATRX knockout (29) . It also seems likely that dosage of ATRX is critical to the development of ATR-X syndrome since the level of the ATRX protein is significantly reduced (3-55%) in all disease cases (this report and (28)). Even the splicing mutations produce full-length protein and in three of these mutants [4317G . A (two cases) and 6218-12574G . A], the full-length protein would be structurally normal. As we can detect no mutant protein in any of these cases, it is unlikely they act via a dominant negative effect and low levels of ATRX alone (between 3 and 10% of normal levels) account for syndrome development.
It appears therefore that, in most cases, a significant deficiency of the ATRX protein results in ATR-X syndrome underlying the importance of protein instability in mongenic disease (30) . Placing the mutants in a structural model has 
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given insights as to why they destabilize the protein, knowledge that will prove useful in analysing newly identified ATR-X syndrome mutations. Three patient mutations, V1552F, K1650N and L1746S, are expressed at relatively normal levels (39 -53%). Although it is not clear whether this is due to comparatively normal protein stability or through another mechanism affecting protein turnover, it was of interest to determine whether these mutations might primarily affect ATRX function rather than via low dosage. Like other members of the Rad54 subfamily, we found that the ATPase activity of rATRX is maximally stimulated by DNA rather than nucleosomes. Recombinant V1552F and K1650N proteins were defective in DNA-stimulated ATPase activity. This might be a consequence of a defect in ATP binding/hydrolysis, but given that these mutations are found away from the catalytic core we think this unlikely. Instead, these mutations might affect DNA binding or have a role in communicating the occurrence of DNA binding to the catalytic site. Consistent with this, K1650 is found in a region of the protein that in the crystal structures of the SF2 helicases VASA and Sulfolobus solfataricus Rad54 makes contact with the DNA backbone (13, 31) . Attempts to confirm this hypothesis with the mutant proteins using standard electrophoretic mobility shift assay conditions has, however, been hampered by the protein precipitating in the wells of the gel.
In contrast, L1746S showed normal DNA-stimulated ATP hydrolysis and remarkably generated a high level of ATPase activity in the absence of DNA. This uncoupling of ATPase activity from DNA stimulation has not, so far as we are aware, been previously observed in a human mutation.
One measureable activity of Snf2 proteins is their ability to translocate across DNA and this study confirms that rATRX translocates across DNA in an ATP-dependent manner (22) . Snf2 proteins may convert this movement into various useful applications in a wide variety of nuclear functions, most often to remodel or remove nucleosomes. Recently, an ATRX -DAXX complex has been shown to assemble H3.3-containing nucleosomes, an activity that may be used to deposit H3.3 at telomeric repeats (4 -6).
All three functional ATRX mutations identified in this study are defective in DNA translocation. Given their severe phenotypic consequences, they provide evidence that DNA translocation is required for in vivo function. The V1552F mutation shows both impaired ATPase and DNA translocase activities. This is an interesting mutation as it lies upstream of the most highly conserved sequences and potentially represents a region not previously recognized as functionally important.
The L1746S mutation identified here addresses a key question associated with this group of proteins; how is the activity of ATP hydrolysis converted, via intramolecular interactions, into useful activity? L1746S lies within conserved helicase motif III (Supplementary Material, Fig. S6 ) and both structural and mutagenesis studies suggest that this motif makes intramolecular interactions with motifs II and VI as part of an extended series of contacts around the ATPase site that also includes motifs Ia and V (31, 32) . In so doing it has been suggested that motif III co-ordinates nucleic acid binding with ATP hydrolysis (33) . The L1746S mutation has uncoupled that co-ordination allowing ATP hydrolysis to proceed in the absence of DNA. How the mutation disrupts the co-ordinating role of motif III is unclear but it identifies an area of motif III that has not previously been targeted for mutagenesis as being important for activity.
The mutation replaces a hydrophobic residue with a polar OH group that has the potential to interact with residues in both motif I and motif II, 4 -5 Å distant. One possible explanation for the behaviour of this mutation is that motif III not only communicates the state of ATPase activity but also DNA binding with the L1746S mutation perhaps switching motif III into a permanently 'on' state signalling that DNA is bound even in its absence, causing the continued futile hydrolysis of ATP. A connection with nucleic acid binding and motif III has recently been shown in the DEAD-box RNA helicase Ded1 (33) . It was suggested that binding of ATP promotes the creation of a high-affinity nucleic acid binding site mediated by motif III and binding of nucleic acid in turn promotes ATP hydrolysis. It is possible that the L1746S mutation mimics this high-affinity nucleic acid bound state.
This analysis has identified a rare and informative mutation (L1746S) in which ATP hydrolysis is not only uncoupled from DNA translocation but also from DNA binding generating a molecular motor that continues to turn over ATP but is defective in driving along DNA.
MATERIALS AND METHODS
Patients
The study was approved by the Multi-centre Research Ethics Committee (ref MREC 07/MRE00/70). All the individuals studied had ATR-X syndrome with severe to profound mental retardation as defined in the ICD-10 classification (34) . The presence of genital abnormalities and alpha-thalassaemia are shown in Supplementary Material, Table S2 .
Materials
Nucleosomes 243 and DNA 243 were kindly provided by Lynda Chapman and Daniela Rhodes (MRC Laboratory of Molecular Biology, Cambridge). The histone octamer was positioned on the Widom 601 nucleosome-positioning sequence (35) . Nucleosome 243 had 48 nucleotides extending beyond either end of the nucleosome core.
Preparation and quantification of ATRX mRNA and protein
This was done as previously described (28) . ATRX was detected using 39F as the primary antibody (36) . In every western blot, the same normal extract was used for comparison. Levels of full-length ATRX are expressed relative to the average for normal individuals. Protein loading was checked and corrected by re-probing with antibody to Sin3A (Abcam, Cambridge, UK).
ATRX expression and purification
ATRX was over-expressed and purified from insect cells using the Bac-to-Bac method (Invitrogen, Paisley, UK) as follows. The full-length ATRX expression vector was a gift from David Picketts (23) . ATRX was subsequently cloned into pFastBacHTB (Invitrogen) with a 3 ′ HA tag sequence and transformed into DH10Bac to generate recombinant bacmids. Successful transposition was confirmed by PCR. Infectious viral particles were generated by transfection of the bacmid into Sf9 cells and virus was further amplified to generate high titre virus. For ATRX protein expression, 2 L of insect cells at 1 × 10 6 cells per ml were infected with virus and cells harvested after 48 h. After washing in phosphate buffered saline, cells were resuspended in Hepes lysis buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.5, 0.5 M NaCl, 10 mM KCl, 2 mM MgCl 2 , 20% glycerol, 0.1% NP-40, 0.2 mM ethylenediaminetetraacetic acid (EDTA) and 0.2 mM dithiothreitol (DTT) together with protease inhibitors). Cells were lysed with a Dounce homogenizer, clarified by centrifugation before incubation with Ezview red anti-HA affinity gel (Sigma, St Louis, MO, USA). The gel was washed four times with 20 mM HEPES pH 7.5, 0.9 M NaCl, 10 mM KCl, 2 mM MgCl 2 , 20% glycerol, 0.01% NP-40, 0.1% Tween, 0.2 mM EDTA and 0.2 mM DTT together with protease inhibitors. ATRX was eluted with HA peptide at 100 mg/ml in Hepes lysis buffer, frozen in aliquots on dry ice and stored at 2708C.
ATRX mutagenesis
Mutations were introduced into ATRX by site-directed mutagenesis using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). Primer sequences are in the supporting information. Expression and purification of mutant proteins were carried out as above.
ATPase assay
Reactions were performed in a buffer containing 25 mM HEPES pH 7.5, 5% glycerol, 10 mM KCl, 5 mM MgCl 2 , 50 mM ATP, 0.005% NP-40, 0.2 mM DTT, 100 mg/ml bovine serum albumin (BSA) and 2.5 mCi [g-32 P]-ATP at 3000 Ci/mmol. The concentration of added ATRX, nucleic acid or nucleosome is indicated in the relevant figure. The reaction was incubated at 308C for 30 min and stopped by spotting 1 ml onto polyethyleneimine-cellulose plates. Spots were allowed to dry and products separated by thin layer chromatography (TLC) in 0.75 M KH 2 PO 4 pH 3.5. After drying, the TLC plate was exposed to a phosphor screen, developed on Typhoon (GE Healthcare, Amersham, UK) and spot intensity quantified using Image Quant TL v2005 (GE Healthcare). Background intensity was deducted from the lane profiles using the rolling ball method. The results are expressed as a percentage of hydrolysed [g- 
Homology modelling
Structure prediction was performed using the PHYRE program (http://www.sbg.bio.ic.ac.uk/~phyre/). Phyre is a fully automated protein modelling resource. It uses a sensitive profile -profile alignment algorithm, comparing both sequence and secondary structure profiles, to reliably detect homologues with mutual sequence identity down to 10-15%.
Models were built for the wild-type structure and each of the previously described missense mutations with the exception of V1538G and V1552F that lie outside the region of homology. The modelled region stretched from residues 1560-2259. Because of a lack of sequence homology, the following residues were omitted from the structure: 1577-1580, 1688-1702, 1879-1881, 1910-2005, 2057-2078, 2106 and 2249-2253. Structures were viewed using VMD 1.8.3 (37) .
Triple helix displacement assay
Triple helix displacement experiments were performed based on previously published methods (38) (39) (40) . The triplex forming oligo (TFO) (AAAGAAGAAAGAGAAAAGAA) was end labelled with 33 P and annealed to a 2-fold excess of EcoRI cut pSV20 in 25 mM 2-(N-morpholino)ethanesulfonic acid pH 5.5, 10 mM MgCl 2 by heating to 608C for 15 min and slowly cooling. Displacement reactions were performed at 308C using 1 -2 nM triple helix, 100 nM protein in a buffer of 50 mM Hepes pH 7.25, 50 mM NaCl, 10 mM MgCl 2 , 10 mM KCl, 5% glycerol, 100 mg/ml BSA and 1 mM DTT. The reaction was followed at 15 min intervals and stopped using 40 mM tris acetate pH 7, 0.1% sodium dodecyl sulfate, 3% glycerol, 10 mM MgCl 2 , and 0.8 mM bromophenol blue. Products were resolved on a 6% native polyacrylamide gel at 48C, the gel dried and exposed to phosphor screen, developed on Typhoon (GE Healthcare) and band intensity quantified using Image Quant TL v2005 (GE Healthcare). Background intensity was deducted from the lane profiles using the rolling ball method. The percentage of displaced TFO ¼ 100 × TFO/(TFO + Triple helix). Results are expressed as the average of at least three independent experiments and error bars represent 1 SD.
